Home › Funds › MPM BioImpact LLC › ZURA
MPM BioImpact LLC position in ZURA
ZURA BIO LTD · Health Care
MPM BioImpact LLC reported holding 4,449,671 shares of ZURA (ZURA BIO LTD) in its Q3 2026 13F filing — a position valued at US$18.5M, representing 1.42% of its reported portfolio and ranking #30 among its reported holdings. MPM BioImpact LLC has disclosed ZURA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ZURA position evolved
MPM BioImpact LLC first disclosed a stake in ZURA in Q2 2026 at 4,472,843 shares (US$26.4M). Across 2 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,449,671 shares valued at US$18.5M — a reduction of -23,172 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 4.47M | $26.39M | New |
| Q3 2026 | 4.45M | $18.51M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZURA and 13F data
ZURA (ZURA BIO LTD) is a Health Care company. 42 other funds we track also report a position in ZURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$39.3M), Venrock Adviser, LLC (US$26.8M), GREAT POINT PARTNERS LLC (US$17.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZURA
- MONTANOVA CAPITAL, LLC 9.44M sh · $39.28M · Q3 2026
- Venrock Adviser, LLC 6.43M sh · $26.77M · Q3 2026
- GREAT POINT PARTNERS LLC 4.08M sh · $16.96M · Q3 2026
- Commodore Capital LP 3.25M sh · $13.52M · Q3 2026
- Saturn V Capital Management LP 2.03M sh · $8.46M · Q3 2026
- Vestal Point Capital, LP 1.86M sh · $7.74M · Q3 2026
- Foresite Capital Management VI LLC 1.76M sh · $7.31M · Q3 2026
- QVT Financial LP 1.67M sh · $6.94M · Q3 2026
- Squadron Capital Management LLC 1.20M sh · $4.99M · Q3 2026
- Ikarian Capital, LLC 1.02M sh · $4.24M · Q3 2026
- Blue Owl Capital Holdings LP 735.00K sh · $3.06M · Q3 2026
- EcoR1 Capital, LLC 679.72K sh · $2.83M · Q3 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ZURA?
MPM BioImpact LLC has disclosed ZURA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is MPM BioImpact LLC's current position in ZURA?
As of Q3 2026, MPM BioImpact LLC holds 4.45M shares of ZURA (ZURA BIO LTD), valued at $18.51M, representing 1.42% of its reported portfolio and ranking #30.
Has MPM BioImpact LLC been buying or selling ZURA?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC reduced its position in ZURA.
Which other funds hold ZURA?
Other major institutional holders of ZURA include MONTANOVA CAPITAL, LLC, Venrock Adviser, LLC, GREAT POINT PARTNERS LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.